Which knee cartilage defects are actually repairable

Not every knee cartilage problem is a candidate for surgical repair — and the distinction matters before a procedure is even named.

Articular cartilage has no intrinsic capacity to heal itself after significant injury. Chondrocytes, the cells responsible for maintaining cartilage tissue, cannot regenerate in sufficient numbers once a full-thickness defect forms. Without surgical intervention, a Grade III or IV focal lesion — one penetrating to or near the subchondral bone — will not resolve on its own.

The repair window applies specifically to focal chondral defects: discrete, contained lesions surrounded by structurally healthy cartilage. Diffuse joint degeneration — established osteoarthritis — falls outside the scope of both single-stage and two-stage techniques; neither approach functions without an intact joint environment, competent menisci, correct mechanical alignment, and stable ligaments. If those preconditions are absent, cartilage restoration is not appropriate and the pathway shifts towards joint preservation or replacement.

Age is a real modifier. Outcomes are consistently stronger in patients under 40, and for younger active patients the arithmetic of early joint replacement is unfavourable: total knee replacement survivorship falls to roughly 52–65% at 40 years when surgery is performed at that age, with a lifetime revision risk of up to 35%. Cartilage repair preserves those future options in a way that arthroplasty cannot.

For patients who do have a focal, full-thickness defect in an otherwise sound knee, the next question is which procedure best matches the defect characteristics — and that is where the single-stage versus two-stage decision begins.

What separates a single-stage from a two-stage procedure

The core structural difference is straightforward: a two-stage procedure requires two separate anaesthetic events, while a single-stage approach completes the entire repair in one operative session.

For two-stage techniques — principally ACI and its matrix-based variant MACI — the first operation is an arthroscopic biopsy to harvest a small cartilage sample from a non-weight-bearing area of the knee. That tissue is sent to a laboratory where chondrocytes are isolated and expanded in culture over four to six weeks. The second procedure then returns those cells — in MACI, seeded onto a Type I/III collagen membrane — to the defect site. This cell expansion phase is where the biological rationale lies: MACI implants are designed to generate hyaline-like repair tissue, which is structurally closer to native cartilage than the fibrocartilage produced by marrow-stimulation methods.

Single-stage procedures — including AMIC (matrix-augmented microfracture), minced autologous cartilage implantation, and OATS (osteochondral autograft transfer) — eliminate the laboratory step entirely. The repair material is prepared and placed during the same session, removing a second surgical event and its associated recovery.

Microfracture, the oldest single-stage technique, held a historical first-line role but current evidence documents fibrocartilage breakdown by two to three years and subchondral bone plate damage that can limit future repair options. It is not considered a modern first choice for active patients with significant defects.

An emerging approach, STACI (single-treatment ACI), aims to deliver cell-based repair in one stage; clinical evidence remains early and insufficient to guide routine use.

ChondroFiller injection — an acellular collagen scaffold placed under ultrasound guidance as an outpatient procedure — sits outside these surgical categories and is considered separately below.

Choosing between the two approaches: the key clinical factors

Defect size is the primary decision point. For contained lesions under 2 cm², single-stage marrow-stimulation techniques such as AMIC have historically been used; OATS or mosaicplasty suits the 1–4 cm² range where a structural plug graft is feasible without unacceptable donor-site trade-offs. Once a focal defect exceeds 3 cm² in an otherwise healthy knee, two-stage cell-based repair — typically MACI — becomes the preferred route, with evidence supporting its use up to around 10 cm² in active adults aged 18–55.

Location and lesion depth add a second layer. Full-thickness defects on load-bearing condylar surfaces — particularly the medial or lateral femoral condyle — place the highest demand on repair tissue under cyclical compressive load. Those lesions tend to favour cell-based techniques that produce hyaline-like tissue. Smaller, more peripheral or trochlear lesions may suit single-stage scaffold approaches, including ChondroFiller injection, an outpatient ultrasound-guided collagen scaffold option discussed in the next section.

Activity level is the third variable. For patients aiming to return to high-impact sport — running, pivoting, cutting — hyaline-like repair tissue carries a distinct durability advantage over fibrocartilage, which tends to break down under repeated impact loading. Surgeons evaluating athletes will therefore weigh tissue type directly against competitive demands, and published evidence consistently shows earlier repair produces better return-to-sport rates across all techniques.

Surgical history also enters the calculation. Clinical evidence indicates that prior marrow-stimulation procedures — microfracture in particular — raise the failure risk for subsequent ACI, making early defect characterisation an important consideration.

Finally, mechanical alignment is a prerequisite rather than an afterthought. Where malalignment loads the defect compartment disproportionately, an osteotomy (HTO or DFO) may be required before or alongside cartilage repair to give the graft a sound mechanical environment in which to mature.

What the evidence shows about durability and outcomes

The strongest durability evidence in this space comes from MACI's long-term registry. In a series of 168 patients followed for a minimum of ten years (mean age 37 at surgery), the all-cause reoperation rate was 9.0% and progression to total knee arthroplasty occurred in 7.4% of cases, with patient-reported outcomes showing durable improvement throughout. That dataset provides the most mature available picture of cartilage repair under a decade of real-world loading.

Single-stage results are closing the gap. HA-BMAC — a one-step procedure combining hyaluronic acid with bone marrow aspirate concentrate — achieved Kaplan-Meier survival of 92% at five years and 88% at ten years for full-thickness lesions. These figures sit within a clinically competitive range, though single-stage evidence has not yet accumulated the multi-decade registry depth that underpins MACI's record.

Two recent comparisons sharpen the shorter-term picture. A 2026 matched cohort of 82 patients found that minced autologous cartilage transplantation and HA-BMAC delivered statistically equivalent improvements across all KOOS subscales (KOOS — a standardised patient-reported index covering pain, symptoms, and knee function) at one year. MRI biological healing trended in favour of minced cartilage: MOCART-2 scores (a validated imaging measure of repair tissue fill and quality, scored 0–100) averaged 77 versus 73, with excellent fill — above 80 — in 51% of minced cartilage cases compared with 38% in the HA-BMAC group. Whether that imaging difference translates into longer-term functional advantage remains an open question. Separately, a 2025 matched-pair analysis found single-stage minced cartilage implantation and two-stage ACI produced comparable patient-reported scores at 24 months for medium-to-large defects, with similar reoperation rates.

The evidence gap is worth stating plainly. No randomised controlled trial yet compares single-stage and two-stage techniques in the same defect-size category beyond five to eight years. Short-to-mid-term equivalence on patient-reported scores is an encouraging signal, but it does not establish equivalent tissue durability under sustained impact loading — the question that matters most for patients aiming to return to high-demand sport over years rather than seasons.

Recovery timelines: what active patients should realistically expect

Planning a return to sport around cartilage repair demands more than knowing which operation was performed — it requires understanding that one anaesthetic does not equal a faster recovery.

Two-stage MACI: a structured 9–12 month pathway

For MACI, rehabilitation begins the morning after implantation and unfolds in five clearly defined phases. The first weeks involve protected weight-bearing on crutches, with the knee in a brace and limited to isometric muscle work. From roughly weeks six to twelve, patients move to stationary cycling and gait retraining. Phase three — progressive closed-chain loading including leg press, step-ups, and balance drills — typically runs from months three to six. Straight-line jogging and dynamic control exercises follow. Sport-specific cutting, pivoting, and sprinting drills are introduced only in phase five, and competitive clearance requires a follow-up MRI to confirm graft maturation before the patient returns to contact or high-impact activity. The full protocol spans nine to twelve months from implantation — and for two-stage patients, this clock starts only after the second operation. The biopsy-to-implantation gap of four to six weeks for laboratory cell expansion is an additional planning reality that precedes all of that.

Single-stage: one episode, similar maturation demands

Single-stage procedures eliminate that preliminary gap and the second anaesthetic, but the cartilage maturation phase itself cannot be compressed. Published rehabilitation frameworks for single-stage techniques still run to six to nine months before return to high-impact sport. The practical advantage is one recovery episode, not a shorter one.

What that timeline can look like under demanding conditions is illustrated by a published case of a 21-year-old Division I American football player who underwent MACI for three simultaneous full-thickness knee defects and returned to full contact sport at nine months post-operatively. That result demonstrates what is achievable under optimal biological and compliance conditions — it should not set the expectation for every patient.

Regardless of technique, protocol adherence — particularly the MRI clearance checkpoint — is as consequential as the surgical choice itself. Athletes planning around a fixed return date, rather than around graft readiness, carry a higher risk of early failure.

Getting the right assessment at Lincolnshire Knee

Choosing between single-stage and two-stage repair is not a decision any patient can reach alone — it depends on precise characterisation of the defect: its size, depth, ICRS grade, the condition of the surrounding cartilage, and whether abnormal joint loading means an alignment correction needs to accompany the repair itself. That information requires specialist imaging and clinical assessment, not a symptom description.

Objective defect characterisation benefits from MRI capable of cartilage segmentation and T2 mapping — the kind of tissue-level detail that distinguishes a focal repairable lesion from early diffuse degeneration. Where alignment or load distribution is in question, objective gait and biomechanical data help clarify whether an osteotomy adjunct belongs in the plan.

Lincolnshire Knee — part of the MSK Doctors group — offers consultant-led assessment at Sleaford NG34 (which houses an Open MRI suite and Regeneration Hub) and Grantham NG31. The assessment pathway includes onMRI™ AI-driven cartilage MRI analysis and MAI Motion® biomechanical assessment where clinically indicated. No GP referral is needed.

Book an assessment at lincolnshireknee.co.uk.

1. [1] Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee. (2024). https://doi.org/10.1177/03635465231205309 https://doi.org/10.1177/03635465231205309
2. [2] Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and Are Safe for Single-Stage Cartilage Repair in Humans upon Mixture with Recycled Autologous Chondrons. (2017). https://doi.org/10.1002/stem.2475 https://doi.org/10.1002/stem.2475
3. [3] Scientific Evidence Base for Cartilage Injury and Repair in the Athlete. (2012). https://doi.org/10.1177/1947603511415841 https://doi.org/10.1177/1947603511415841
4. [4] Multiple Lesion Matrix-Induced Chondrocyte Implantation Procedure in a Collegiate Football Athlete. (2021). https://doi.org/10.2106/JBJS.CC.21.00158 https://doi.org/10.2106/JBJS.CC.21.00158
5. [5] Early health economic modelling of single-stage cartilage repair. Guiding implementation of technologies in regenerative medicine. (2017). https://doi.org/10.1002/term.2197 https://doi.org/10.1002/term.2197